Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Antiviral%22&type=Subject&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?lookfor=%22Antiviral%22&type=Subject&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?lookfor=%22Antiviral%22&type=Subject&filter%5B%5D=collection%3ACTG
PubPharm (101)
1
High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients being null responders to prior dual therapy with peginterferon alpha and ribavirin – a proof-of-concept trial on antiviral efficacy and safety : High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients being null responders to prior dual therapy with peginterferon alpha and ribavirin – a proof-of-concept trial on antiviral efficacy and safety - HISTORY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients being null responders to prior dual therapy with peginterferon alpha and ribavirin – a proof-of-concept trial on antiviral efficacy and safety : High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients being null responders to prior dual therapy with peginterferon alpha and ribavirin – a proof-of-concept trial on antiviral efficacy and safety - HISTORY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Serum Angiotensin II Level in Chronic Hepatitis C Patients Who Achieved Sustained Virologic Response after Direct Antiviral Agent Therapy : Serum Angiotensin II Level in Chronic Hepatitis C Patients Who Achieved Sustained Virologic Response after Direct Antiviral Agent Therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A Bioequivalence Study of Two Formulations of 1 mg Entecavir Film-coated Tablets in Healthy Thai Volunteers under Fasting Condition : A Bioequivalence Study of Entecavir Film-coated Tablets under Fasting Condition
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A Bioequivalence Study of Two Formulations of 1 mg Entecavir Film-coated Tablets in Healthy Thai Volunteers under Fasting Condition : A Bioequivalence Study of Entecavir Film-coated Tablets under Fasting Condition
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Hepatitis B surface antigen, core-related antigen and HBV RNA: Predicting clinical relapse after NA therapy discontinuation : The Role of Quantitative Hepatitis B surface antigen, Hepatitis B core related antigen and Hepatitis B RNA in Prediction of Hepatitis B Relapse after Nucleos(t)ides Analogues Discontinuation in Chronic Hepatitis B.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: A randomized controlled trial : Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: A randomized controlled trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Preliminary study on effect of high dose of Andrographis paniculata extract capsule in mild COVID-19 patients : Preliminary study on effect of high dose of Andrographis paniculata extract capsule in mild COVID-19 patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Serum Angiotensin II Level in Chronic Hepatitis C Patients Who Achieved Sustained Virologic Response after Direct Antiviral Agent Therapy : Serum Angiotensin II Level in Chronic Hepatitis C Patients Who Achieved Sustained Virologic Response after Direct Antiviral Agent Therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A Bioequivalence Study of Two Formulations of 1 mg Entecavir Film-coated Tablets in Healthy Thai Volunteers under Fasting Condition : A Bioequivalence Study of Entecavir Film-coated Tablets under Fasting Condition
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
101
Aufsätze
101
E-Artikel
101
E-Ressourcen
Zeitschriftentitel
76
WHO International Clinical Trials Registry Plat...
25
ClinicalTrials.gov
Thema
101
610
78
Study Type: Interventional
41
Recruitment Status: Not yet recruiting
24
Recruitment Status: Completed
21
Study Type: Observational
14
Recruitment Status: Authorised-recruitment may ...
11
Phase: Phase 3
9
Hepatitis
9
Phase: Phase 1
9
Phase: Phase 4
8
Hepatitis C
8
Medical Condition: Chronic hepatitis C patients...
8
Phase: Phase 2
8
Recruitment Status: Recruiting
7
Hepatitis A
6
Recruitment Status: Unknown status
5
Hepatitis, Chronic
4
Drug-Related Side Effects and Adverse Reactions
4
Hepatitis B
4
Hepatitis B, Chronic
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
49
2020-
52
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
95
Englisch
4
Unbestimmt
2
Spanisch
Haven't found what you're looking for?
Wird geladen...